Kiora Pharmaceuticals Secures US Patent for KIO-104
KIO-104 is for the treatment of a wide range of ocular diseases, including ocular inflammation, uveitis, age-related macular degeneration (AMD), and complications as a result of refractive surgery.
Related Articles
Handheld fundus camera from Optomed USA launched for use in any care setting
Optomed Lumo launches a versatile handheld fundus camera, enhancing retinal imaging accessibility in diverse healthcare settings across the US.
2025 American Society of Retina Specialists Annual Meeting
Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through our magazines, newsletters, and events.
Artificial Intelligence to Enhance YOur Intelligence
AI isn’t the future—it’s now. From triaging urgent cases to detecting retinal disease, AI is changing how we deliver care. Learn how to integrate these…
Previous retinal tear, detachment may increase recurrence risk after cataract surgery
LONG BEACH, Calif. —A previous retinal tear or retinal detachment may be a risk factor for developing a recurrent phakic retinal tear after cataract surgery,…
Q&A: The potential impact of vitamin D on retinal surgery
Steven D. Ness, MD, discusses his research on vitamin D’s role in reducing complications after retinal surgery at ASRS 2025.
EyePoint completes enrollment of LUGANO and LUCIA trials
EyePoint Pharmaceuticals completes enrollment for the LUCIA trial, advancing DURAVYU’s potential as a new treatment for wet AMD.
Opus Genetics partners with Global RDH12 Alliance
Opus Genetics partners with the Global RDH12 Alliance to advance gene therapy for inherited retinal disease, aiming for FDA application by late 2025.
Video: Surgical Retina Takes Center Stage at ASRS 2025
Gaurav Shah, MD, who planned the program for the annual meeting, explains why the first day was all about surgery.
2025 American Society of Retina Specialists Annual Meeting
Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through our magazines, newsletters, and events.
Week in Review: Monocular Blindness After Open Globe Injury, Myopia in Children With ADHD, Depression and Anxiety Among Patients With Glaucoma
Type of health insurance and other factors might impact blindness development after open globe injury, lower myopia rates are seen in a cohort of children…